Have a personal or library account? Click to login
Therapeutic Drug Monitoring of Venlafaxine and Impact of Age, Gender, BMI, and Diagnosis Cover

Therapeutic Drug Monitoring of Venlafaxine and Impact of Age, Gender, BMI, and Diagnosis

Open Access
|Nov 2020

Authors

M. Krivosova

krivosova6@uniba.sk

Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital Martin, Martin, Slovakia

M. Kertys

Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital Martin, Martin, Slovakia

M. Grendar

Bioinformatics Unit of Biomedical Centre Martin, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital Martin, Martin, Slovakia

I. Ondrejka

Psychiatric Clinic, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital Martin, Martin, Slovakia

I. Hrtanek

Psychiatric Clinic, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital Martin, Martin, Slovakia

I. Tonhajzerova

Department of Physiology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital Martin, Martin, Slovakia

N. Sekaninova

Department of Physiology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital Martin, Martin, Slovakia

J. Mokry

Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital Martin, Martin, Slovakia
Language: English
Page range: 33 - 37
Submitted on: Feb 28, 2020
Accepted on: Jun 24, 2020
Published on: Nov 18, 2020
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:

© 2020 M. Krivosova, M. Kertys, M. Grendar, I. Ondrejka, I. Hrtanek, I. Tonhajzerova, N. Sekaninova, J. Mokry, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.